Supply Chain

Deutsche Post DHL Group on Wednesday launched software that uses machine learning algorithms and natural language processing to predict supply chain risks.

Nevada seeks to better regulate the cost of prescription drugs with a new bill, reports Business Insider.

GW Pharmaceuticals' experimental epilepsy drug, derived from marijuana, may be the first drug of its kind to earn regulatory approval, reports Business Insider.

Most Americans agree — prescription drug prices are out of control.

Here are the four latest drugs or medical devices approved by the Food and Drug Administration this week.

Journalist Charles Seifi on Thursday filed a federal lawsuit against the Food and Drug Administration over the withholding of documents surrounding the controversial approval of Exondys 51, a Duchenne muscular dystrophy drug, reports Boston Business Journal.

Two former executives of Eatontown, N.J.-based Heritage Pharmaceuticals reached a settlement with 41 states after pleading guilty to fixing drug prices, reports Reuters.

Food and Drug Administration new drug approvals are rebounding this year, following slowdown in 2016, reports Reuters.

Here are six articles published by Becker's Hospital Review this week, highlighting a nationwide recall of an Abbott heart pump controller, a massive shortage of sodium bicarbonate solution in hospitals and more.

Abbott Laboratories recalled nearly 29,000 controllers used with an implanted blood pump after more than two dozen heart patients died trying to replace the controller outside of a hospital setting.